Literature DB >> 32733115

Use of Clozapine in the General Hospital.

Feras Ali Mustafa1.   

Abstract

Patients with treatment-resistant schizophrenia receiving clozapine therapy are at risk of potentially serious complications in the general hospital setting, due to the complex pharmacokinetic and pharmacodynamic profile of clozapine. We summarize common clinical challenges that face clinicians who care for clozapine patients in the general hospital, and make recommendations based on the available literature and clinical experience. Early collaborative management between consultation-liaison psychiatry and other clinical teams in the general hospital is paramount to improve clinical outcomes and avoid serious complications in this patient group.
Copyright © 1964–2019 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.

Entities:  

Keywords:  clozapine; consultation-liaison psychiatry; general hospital; treatment-resistant schizophrenia

Mesh:

Substances:

Year:  2020        PMID: 32733115      PMCID: PMC7377545     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  32 in total

1.  Around 3% of 1,300 Levels Were Elevated during Infections in a Retrospective Review of 131 Beijing Hospital In-Patients with More than 24,000 Days of Clozapine Treatment.

Authors:  Can-Jun Ruan; Yan-Nan Zang; Yu-Hang Cheng; Chuan-Yue Wang; José de Leon
Journal:  Psychother Psychosom       Date:  2020-02-28       Impact factor: 17.659

2.  Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study.

Authors:  P Kugathasan; B Stubbs; J Aagaard; S E Jensen; T Munk Laursen; R E Nielsen
Journal:  Acta Psychiatr Scand       Date:  2019-08-07       Impact factor: 6.392

Review 3.  Schizophrenia past clozapine: what works?

Authors:  Feras Ali Mustafa
Journal:  J Clin Psychopharmacol       Date:  2013-02       Impact factor: 3.153

4.  Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-09       Impact factor: 5.067

5.  Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.

Authors:  T M Shiovitz; T L Welke; P D Tigel; R Anand; R D Hartman; J J Sramek; N M Kurtz; N R Cutler
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

6.  [Clozapine use and abrupt smoking cessation; a potentially life-threatening combination].

Authors:  A Ruissen; A M van Schaik; J H Beijnen
Journal:  Tijdschr Psychiatr       Date:  2009

7.  Ciprofloxacin strongly inhibits clozapine metabolism: two case reports.

Authors:  E E M Brouwers; M Söhne; S Kuipers; E C M van Gorp; J H M Schellens; C H W Koks; J H Beijnen; A D R Huitema
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

8.  Toxic rise of clozapine plasma concentrations in relation to inflammation.

Authors:  Marie Jeanne Haack; M L F J Bak; Rob Beurskens; Michael Maes; L M L Stolk; Philippe A E G Delespaul
Journal:  Eur Neuropsychopharmacol       Date:  2003-10       Impact factor: 4.600

9.  Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.

Authors:  Christoph U Correll; Thomas Brevig; Cecilia Brain
Journal:  BMC Psychiatry       Date:  2019-11-14       Impact factor: 3.630

10.  Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID).

Authors:  Mark James Ponsford; Rachael Steven; Kathyrn Bramhall; Mathew Burgess; Sonali Wijetilleka; Emily Carne; Frances McGuire; Colin R Price; Mo Moody; Soha Zouwail; Tayyeb Tahir; Daniel Farewell; Tariq El-Shanawany; Stephen R A Jolles
Journal:  J Clin Pathol       Date:  2020-02-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.